Wist, Erik

Ribociclib as first-line therapy for HR-positive, advanced breast cancer

Hortobagyi, G. N., Stemmer, S. M., Burris, H. A., Yap, Y.-S., Sonke, G. S., Paluch-Shimon, S., Campone, M., Blackwell, K. L., André, F., Winer, E. P., et al. (2016) · New England Journal of Medicine

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 2,039

Fear of recurrence in long‐term testicular cancer survivors

Skaali, T., Fosså, S. D., Bremnes, R., Dahl, O., Haaland, C. F., Hauge, E. R., Klepp, O. N., Oldenburg, J., Wist, E., & Dahl, A. A. (2009) · Psycho-Oncology

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 180

Study of anxiety disorder and depression in long-term survivors of testicular cancer

Dahl, A. A., Haaland, C. F., Mykletun, A., Bremnes, R., Dahl, O., Klepp, O., Wist, E., & Fosså, S. D. (2005) · Journal of Clinical Oncology

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 176

Fatigue During and After Breast Cancer Therapy—A Prospective Study

Reinertsen, K. V., Engebraaten, O., Loge, J. H., Cvancarova, M., Naume, B., Wist, E., Edvardsen, H., Wille, E., Bjøro, T., & Kiserud, C. E. (2017) · Journal of Pain and Symptom Management

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 71

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

von der Lippe Gythfeldt, H., Lien, T., Tekpli, X., Silwal‐Pandit, L., Borgen, E., Garred, Ø., Skjerven, H., Schlichting, E., Lundgren, S., Wist, E., et al. (2020) · International Journal of Cancer

Breast Cancer Treatment StudiesAngiogenesis and VEGF in Cancer

Cited by 20